These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 148651)

  • 1. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination.
    Cammer W; Bloom BR; Norton WT; Gordon S
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1554-8. PubMed ID: 148651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral proteinases secreted by macrophages degrade basic protein: a possible mechanism of inflammatory demyelination.
    Norton WT; Cammer W; Bloom BR; Gordon S
    Adv Exp Med Biol; 1978; 100():365-81. PubMed ID: 80946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination.
    Cammer W; Brosnan CF; Basile C; Bloom BR; Norton WT
    Brain Res; 1986 Jan; 364(1):91-101. PubMed ID: 2936427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of the P0, P1, and Pr proteins in peripheral nervous system myelin by plasmin: implications regarding the role of macrophages in demyelinating diseases.
    Cammer W; Brosnan CF; Bloom BR; Norton WT
    J Neurochem; 1981 Apr; 36(4):1506-14. PubMed ID: 6167674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators.
    Drapier JC; Tenu JP; Lemaire G; Petit JF
    Biochimie; 1979; 61(4):463-71. PubMed ID: 486577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process.
    Gordon S; Unkeless JC; Cohn ZA
    J Exp Med; 1974 Oct; 140(4):995-1010. PubMed ID: 4427092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
    Chapman HA; Vavrin Z; Hibbs JB
    Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of plasminogen activator by stimulated macrophages.
    Unkeless JC; Gordon S; Reich E
    J Exp Med; 1974 Apr; 139(4):834-50. PubMed ID: 4816302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage proteases and rheumatic diseases: regulation of plasminogen activator by thymus-derived lymphocytes.
    Gordon S; Newman W; Bloom B
    Agents Actions; 1978 Jan; 8(1-2):19-26. PubMed ID: 345780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral protease activation of peritoneal macrophage prostaglandin synthesis.
    Chang J; Wigley F; Newcombe D
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4736-40. PubMed ID: 7001465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-operation between plasmin and elastase in elastin degradation by intact murine macrophages.
    Chapman HA; Stone OL
    Biochem J; 1984 Sep; 222(3):721-8. PubMed ID: 6237643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.
    Werb Z
    J Exp Med; 1978 Jun; 147(6):1695-1712. PubMed ID: 210248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
    Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
    J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage plasminogen activator: induction by products of activated lymphoid cells.
    Vassalli JD; Reich E
    J Exp Med; 1977 Feb; 145(2):429-37. PubMed ID: 833546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids.
    Hamilton J; Vassalli JD; Reich E
    J Exp Med; 1976 Dec; 144(6):1689-94. PubMed ID: 1003109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of macrophage protease activity by acute administration of O,O,S trimethyl phosphorothioate.
    Rodgers KE; Ellefson DD
    Agents Actions; 1990 Mar; 29(3-4):277-85. PubMed ID: 2160188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
    Cuzner ML; Opdenakker G
    J Neuroimmunol; 1999 Feb; 94(1-2):1-14. PubMed ID: 10376931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and suppression of inflammatory demyelination.
    Norton WT; Brosnan CF; Cammer W; Goldmuntz EA
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):225-35. PubMed ID: 2130645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of auranofin and retinoic acid on plasminogen activator activity of peritoneal macrophages and Lewis lung carcinoma cells.
    Lison D; Knoops B; Collette C; Lauwerys R
    Biochem Pharmacol; 1989 Jul; 38(13):2107-12. PubMed ID: 2500127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.